Source:http://linkedlifedata.com/resource/pubmed/id/10397258
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
13
|
| pubmed:dateCreated |
1999-7-28
|
| pubmed:abstractText |
The chromatin-remodeling hSNF5/INI1 gene has recently been shown to act as a tumor suppressor gene in rhabdoid tumors (RTs). In an attempt to further characterize the main chromosomal mechanisms involved in hSNF5/INI1 inactivation in RTs, we report here the molecular cytogenetic data obtained in 12 cell lines harboring hSNF5/INI1 mutations and/or deletions in relation to the molecular genetic analysis using polymorphic markers extended to both extremities of chromosome 22q. On the whole, mitotic recombination occurring in the proximal part of chromosome 22q, as demonstrated in five cases, and nondisjunction/duplication, highly suspected in two cases (processes leading respectively to partial or complete isodisomy), appear to be major mechanisms associated with hSNF5/INI1 inactivation. Such isodisomy accompanies each of the RTs exhibiting two cytogenetically normal chromosomes 22. This results in homozygosity for the mutation at the hSNF5/INI1 locus. An alternate mechanism accounting for hSNF5/INI1 inactivation observed in these tumors is homozygous deletion in the rhabdoid consensus region. This was observed in each of the four tumors carrying a chromosome 22q abnormality and, in particular, in the three tumors with chromosomal translocations. Only one case of our series illustrates the mutation/deletion classical model proposed for the double-hit inactivation of a tumor suppressor gene.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Chromosomal Proteins, Non-Histone,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Genetic Markers,
http://linkedlifedata.com/resource/pubmed/chemical/SMARCB1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jul
|
| pubmed:issn |
0008-5472
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
1
|
| pubmed:volume |
59
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
3152-6
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:10397258-Chromosomal Proteins, Non-Histone,
pubmed-meshheading:10397258-Chromosome Aberrations,
pubmed-meshheading:10397258-Chromosome Mapping,
pubmed-meshheading:10397258-Chromosomes, Human, Pair 22,
pubmed-meshheading:10397258-Consensus Sequence,
pubmed-meshheading:10397258-DNA-Binding Proteins,
pubmed-meshheading:10397258-Gene Deletion,
pubmed-meshheading:10397258-Genes, Tumor Suppressor,
pubmed-meshheading:10397258-Genetic Markers,
pubmed-meshheading:10397258-Homozygote,
pubmed-meshheading:10397258-Humans,
pubmed-meshheading:10397258-In Situ Hybridization, Fluorescence,
pubmed-meshheading:10397258-Karyotyping,
pubmed-meshheading:10397258-Microsatellite Repeats,
pubmed-meshheading:10397258-Mitosis,
pubmed-meshheading:10397258-Mutation,
pubmed-meshheading:10397258-Polymorphism, Genetic,
pubmed-meshheading:10397258-Recombination, Genetic,
pubmed-meshheading:10397258-Rhabdoid Tumor,
pubmed-meshheading:10397258-Transcription Factors,
pubmed-meshheading:10397258-Translocation, Genetic,
pubmed-meshheading:10397258-Tumor Cells, Cultured
|
| pubmed:year |
1999
|
| pubmed:articleTitle |
hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.
|
| pubmed:affiliation |
Pathologie Moléculaire des cancers INSERM U509, Institut Curie, Paris, France.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|